Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 624089, 5 pages
http://dx.doi.org/10.1155/2013/624089
Research Article

Inhibitory Effect of Dodonaea viscosa var. angustifolia on the Virulence Properties of the Oral Pathogens Streptococcus mutans and Porphyromonas gingivalis

Division of Oral Microbiology, Department of Clinical Microbiology and Infectious Diseases, National Health Laboratory Services and Faculty of Health Sciences, University of the Witwatersrand, Private Bag 3, Wits, Gauteng, Johannesburg 2050, South Africa

Received 28 May 2013; Revised 6 September 2013; Accepted 11 September 2013

Academic Editor: Carlo Ventura

Copyright © 2013 Mrudula Patel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Aim. This study investigated the effect of Dodonaea viscosa var. angustifolia (DVA) on the virulence properties of cariogenic Streptococcus mutans and Porphyromonas gingivalis implicated in periodontal diseases. Methods. S. mutans was cultured in tryptone broth containing a crude leaf extract of DVA for 16 hours, and the pH was measured after 10, 12, 14, and 16 h. Biofilms of S. mutans were grown on glass slides for 48 hours and exposed to plant extract for 30 minutes; the adherent cells were reincubated and the pH was measured at various time intervals. Minimum bactericidal concentration of the extracts against the four periodontal pathogens was determined. The effect of the subinhibitory concentration of plant extract on the production of proteinases by P. gingivalis was also evaluated. Results. DVA had no effect on acid production by S. mutans biofilms; however, it significantly inhibited acid production in planktonic cells. Periodontal pathogens were completely eliminated at low concentrations ranging from 0.09 to 0.02 mg/mL of crude plant extracts. At subinhibitory concentrations, DVA significantly reduced Arg-gingipain (24%) and Lys-gingipain (53%) production by P. gingivalis ( ). Conclusions. These results suggest that DVA has the potential to be used to control oral infections including dental caries and periodontal diseases.

1. Introduction

The oral cavity is a complex ecosystem comprising many surfaces coated with a wide variety of species, and an opportunistic microflora which exists in the form of a biofilm may vary due to dietary constituents, systemic illnesses, poor saliva flow, and oral hygiene resulting in the alteration of the microbial communities which leads to the development of oral diseases.

Streptococcus mutans occurs in the oral cavity and has the ability to ferment dietary carbohydrates rapidly and produce acids which are responsible for the demineralization of enamel. The acidic environment also promotes the growth and virulence of the opportunistic pathogen Candida in the oral environment [1, 2]. In addition, it is implicated in root canal infections, odontogenic abscesses, and endocarditis. Soft tissue infections including periodontal disease are caused by obligate oral anaerobic gram negative bacteria, categorized as red and orange complexes of Porphyromonas gingivalis, Fusobacterium nucleatum, Prevotella intermedia, and others [3]. Among these opportunistic pathogens, P. gingivalis is the most aggressive organism mainly because it has the ability to produce proteases, for example, Arg-gingipain and Lys-gingipain as well as lipopolysaccharides, collagenases, and haemagglutinin and is protected by a capsule [4, 5]. In addition, P. gingivalis is linked to systemic diseases such as aortic atherosclerosis, myocarditis, myocardial infarction, and rheumatoid arthritis [68].

Oral hygiene products containing antimicrobial agents such as fluoride and chlorhexidine have been used to control biofilms containing S. mutans and P. gingivalis. In addition, the antimicrobial effect of many natural products has been tested on the virulence properties of S. mutans, that is, biofilm formation and acid production [9, 10].

Inhibitors of proteases produced by P. gingivalis are potentially new therapeutic agents that could control these organisms and related diseases [11]. Dodonaea viscosa var. angustifolia (DVA) also called hopbush, which is traditionally used for many ailments including oral infections [12, 13], is known to inhibit biofilm formation by S. mutans and reduce the virulence of Candida albicans [14, 15]. Furthermore, its cytotoxicity has also been established [16].

This study investigated the effect of a plant extract of the leaves of Dodonaea viscosa var. angustifolia on acid production by S. mutans and protease production by P. gingivalis and the antibacterial effect against P. gingivalis, P. intermedia, F. nucleatum, and Capnocytophaga species.

2. Materials and Methods

2.1. Cultures

Saliva and periodontal pocket debris samples from patients attending the Dental Clinic at Charlotte Maxeke Johannesburg Academic Hospital were collected and cultured on Mutans Bacitracin agar to isolate Streptococcus mutans. Blood agar supplemented with haem and menadione was used to isolate P. gingivalis, Prevotella intermedia, Fusobacterium nucleatum, and Capnocytophaga species. S. mutans cultures were identified using API 20 Strep auxanogram (bioMèrieux), and additional biochemical reactions. S. mutans NCTC 10919 and 4 clinical isolates of S. mutans were used in the study. P. gingivalis, P. intermedia, and F. nucleatum were identified using API 32A and PCR technique [17]. Capnocytophaga spp. was identified using colony morphology and gram stain. Ethical clearance was obtained from The Committee for Research on Human Subjects (Medical), University of the Witwatersrand. Written consent was obtained from the subjects. Cultures were stored at −70°C until required. For each experiment, fresh inoculums containing approximately 106 organisms per millilitre were prepared [14].

2.2. Plant Material and Extract Preparation

Plant material was collected from the Pipeklipberg, Mkhunyane Eco Reserve, Mpumalanga province of South Africa, verified (Voucher Specimens no. J 94882) as described previously [15].

Leaves of Dodonaea viscosa var. angustifolia were dried in the shade and milled to a fine powder. Thereafter, 1.0 g was extracted in 10 mL methanol with vigorous shaking and then centrifuged. The procedure was repeated three times [18]. The solvents were removed under a cold air stream, and a yield of 0.15 g dried extract was obtained. The crude dry extract was weighed and dissolved in DMSO to yield a solution containing 50 mg of crude extract per mL of DMSO. Similarly, extracts were prepared using acetone and ethanol as solvents. Fresh plant extracts were prepared for each experiment.

2.3. Minimum Bactericidal Concentration (MBC)

MBC tests were performed to determine the subinhibitory concentrations for the subsequent experiments. Twofold dilutions of crude plant extract were prepared in microtitre plates using appropriate medium; P. gingivalis and P. intermedia, Tryptone Soy broth containing haem and menadione; Capnocytophaga spp., Tryptone Soy broth; and F. nucleatum, Fusiform media. One hundred microlitres of each of the diluted plant extract was added to each of the 96-well round bottom microtitre plate. Fresh inocula with optical density of 0.2 (405 nm) containing approximately 105-106 organisms per millilitre were prepared, and each well was inoculated with 100 μL of inocula. Microtitre plates containing Capnocytophaga spp. were incubated under CO2 at 37°C for 4 days. Plates containing P. gingivalis, P. intermedia, and F. nucleatum were incubated anaerobically at 37°C for 7 days. Chlorhexidine gluconate was used as a positive control and water as a negative control. Effect of DMSO was also measured. After incubation, each well was subcultured on blood agar. The lowest concentration that had no growth was recorded as MBC for that test organism. Each experiment was repeated in triplicate. Based on the MBC for P. gingivalis, subinhibitory concentrations were selected for the protease inhibition experiments. With S. mutans, the MBC of a previous study was used [14].

2.4. Acid Production by S. mutans

Methanol extract was used for the experiment. The effect of crude plant extract on the acid production by S. mutans grown in biofilms was studied using a technique described by Kim et al. [19], with modifications [19]. Fresh inocula of S. mutans with optical density of 0.2 (405 nm) containing approximately 105-106 organisms per millilitre were prepared. S. mutans biofilms were allowed to grow on glass slides in tryptone broth containing approximately 105 cfu/mL S. mutans for 48 h with a change of the media after 24 h. Biofilms were then exposed to a 0.78 mg/mL subinhibitory concentration of crude plant extract [14] for 30 min and rinsed with phosphate-buffered saline (PBS). Thereafter, the adherent cells were transferred to 30 mL tryptone broth and incubated in CO2 at 37°C. The pH of the media was measured after 2, 4, 6, 8, 13, and 22 h. The effect of crude plant extract on the acid production by planktonic cells of S. mutans was tested by inoculating 30 mL of tryptone broth containing 0.78 mg/mL crude plant extract with 1 mL of inoculum containing 105-106 cfu/mL of S. mutans and incubated for 16 hours. The pH of the media was measured at 0, 10, 12, 14, and 16 h., and the S. mutans count was determined after 0, 12, and 16 hours using the microdilution technique [20].

In both of these experiments water instead of plant extract was used as a control. The effect of DMSO was also measured. Each experiment was repeated in triplicate for the 5 strains of S. mutans that were tested. The results were analysed using the Wilcoxon rank-sum test (Mann-Whitney).

2.5. Protease Inhibition

The inhibitory activity of the methanol plant extract against production of proteinases Arg-gingipain and Lys-gingipain by P. gingivalis was evaluated using the technique of Yamanaka et al. [21] with modifications [21]. P. gingivalis was harvested by centrifugation at 5 000 g for 20 minutes, washed 3 times, resuspended in 50 mM phosphate-buffered saline (pH 7.4), and adjusted to an optical density of 2.0 at 660 nm. Benzoyl-arginine-p-nitroanilide and N-(p-Tosyl)-Gly-Pro-Lys 4-nitroanilide acetate salts in 0.1 M Tris-HCL (pH 8.0) containing 1 mM dithiothreitol were used as substrates for Arg-gingipain and Lys-gingipain, respectively.

One hundred microliters of the substrates was dispensed into the wells of a microtitre plate. Different concentrations of plant extract (including water as a control) and bacterial cell suspensions were added and incubated at 37°C for 20 min. Controls without substrate were included in each plate. Adsorption was measured at a wavelength of 405 nm. Relative enzymatic activity was determined as follows: [(A405 with bacterial cells and plant extract −A405 of control)/(A405 with bacterial cells −A405 of control)] × 100. Each experiment was repeated 10 times. The results were compared to the control, that is, water using Student’s t-test.

3. Results

3.1. MBC

Periodontal pathogens were completely eliminated at low concentrations ranging from 0.09 to 0.02 mg/mL of crude plant extracts (Table 1). All the solvents gave similar results. Based on these results, subinhibitory concentrations (≤0.02 mg/mL) were selected for the virulence study of P. gingivalis. The antimicrobial effect of DMSO was lost at a concentration of 6.125% whereas chlorhexidine gluconate killed all the test organisms.

tab1
Table 1: Minimum bactericidal concentrations of Dodonaea viscosa var. angustifolia against periodontal pathogens.

3.2. Acid Production

DVA had no effect on the acid production by S. mutans biofilms (Figure 1); however, it significantly inhibited acid production in planktonic cells (Figure 2). Bacterial counts in these cultures were performed to eliminate the possible antimicrobial effect of DVA at this subinhibitory concentration. The results showed that there was no significant difference in the bacterial counts of the control and the test cultures . This suggests that reduced acid production was due to the effect of DVA rather than the bacterial growth.

624089.fig.001
Figure 1: Effect of Dodonaea viscosa var. angustifolia on the acid production by biofilm of S. mutans.
624089.fig.002
Figure 2: Effect of Dodonaea viscosa var. angustifolia on the acid production by planktonic S. mutans.
3.3. Proteinase Inhibition

DVA significantly ( ) reduced the Arg-gingipain and Lys-gingipain production by P. gingivalis (Figure 3). The highest reduction of Arg-gingipain was at 0.02 mg/mL DVA (24%) whereas 53% reduction in the production of Lys-gingipain was achieved at 0.01 mg/mL.

624089.fig.003
Figure 3: Effect of Dodonaea viscosa var. angustifolia on the production of Arg-gingipain and Lys-gingipain by Porphyromonas gingivalis. * and **: .

4. Discussion

In the last decade due to the escalation in the development of drug resistance in microorganisms, a novel approach has been proposed whereby the therapeutic agent can target the virulence of causative organisms rather than the number of infectious agents [22, 23]. This approach can be applied to commensals that cause opportunistic infections as they are often not eliminated completely.

This study showed that a subinhibitory concentration of the crude extract of D. viscosa var. angustifolia significantly inhibits acid production by S. mutans, which is an important virulence factor of this organism. S. mutans ferments dietary carbohydrates and produces acids which can cause demineralization of teeth [24]. As demonstrated in this study, the presence of plant extract will not allow S. mutans to produce acid, thereby preventing dental caries. This effect was not dependent on the number of S. mutans because the cfu/mL of S. mutans was not significantly different from the controls. This suggests that the phosphotransferase (PTS) uptake system that assists the transport of glucose could not have been affected by the plant extract. However, conversion of glucose to pyruvate by EMP pathway may have been affected. Polyphenols and tannins are known to interact with cellular enzymes that are responsible for the metabolic pathways, and these compounds have been identified from DVA [14, 2527].

Our results also showed that acid production by S. mutans in the biofilm form is not affected by DVA, though it is known to prevent biofilm formation [14]. If DVA is added to oral hygiene products, regular use will inhibit the plaque formation as well as acid production by planktonic cells of S. mutans. The unfavorable results regarding acid production by the biofilms may have been due to the extracellular polysaccharides that are normally produced in the biofilm by S. mutans. They are tenacious and may have prevented the penetration of many large molecules including chemicals present in the plant extract.

DVA inhibited the growth of some of the anaerobic gram negative bacteria including P. gingivalis that are implicated in soft tissue infections. In addition, it reduced the production of Arg-gingipain by 24% and Lys-gingipain by 53%, which are the most important virulence factors of P. gingivalis. These proteinases downregulate polymorphonuclear neutrophils, modulate host cytokine networks, and degrade proteins which are present in the gingival tissues [21, 28]. Gingipains are essential to P. gingivalis as they provide iron, peptides, and amino acids from environmental proteins [29]. In addition, they are responsible for the cleavage of human transferrin which promotes growth and formation of hydroxyl radicals that play an important role in tissue destruction during infection [30]. Therefore, inhibition of gingipains by DVA will also deprive P. gingivalis of available iron and prevent some tissue destruction. It has been suggested that polyphenols and catechins may be responsible for the antibacterial and antiproteolytic effects against P. gingivalis [21, 30, 31] which are also present in DVA [14].

The results of this study have shown that if DVA is incorporated into a mouth rinse, gel or toothpaste at high concentrations, it will eliminate four of the major periodontal pathogens including P. gingivalis. Even though the concentration of the plant extract is reduced in the oral cavity due to salivary flow, it will render S. mutans and P. gingivalis avirulent. However, further research is needed to identify the active ingredient responsible for the beneficial effects.

5. Conclusions

At subinhibitory concentrations a crude extract of DVA renders S. mutans and P. gingivalis avirulent by preventing acid and proteinase production, respectively. In addition, it kills P. gingivalis, P. intermedia, F. nucleatum, and Capnocytophaga species at low concentrations. This supports the suggestion that the extract of this plant has the potential to be used as preventive and therapeutic agent for the treatment of infections of the mouth.

References

  1. L. P. Samaranayake and T. W. MacFarlane, “Factors affecting the in vitro adherence of the fungal oral pathogen Candida albicans to epithelial cells of human origin,” Archives of Oral Biology, vol. 27, no. 10, pp. 869–873, 1982. View at Google Scholar · View at Scopus
  2. N. Chopde, B. Jawale, B. Pharande, L. Chaudhari, V. Hiremath, and R. Redasani, “Microbial colonization and their relation with potential cofactors in patients with denture stomatitis.,” Journal of Contemporary Dental Practice, vol. 13, pp. 456–459, 2012. View at Google Scholar
  3. A. D. Haffajee, S. S. Socransky, M. R. Patel, and X. Song, “Microbial complexes in supragingival plaque,” Oral Microbiology and Immunology, vol. 23, no. 3, pp. 196–205, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. B. M. Eley and S. W. Cox, “Proteolytic and hydrolytic enzymes from putative periodontal pathogens: characterization, molecular genetics, effects on host defenses and tissues and detection in gingival crevice fluid,” Periodontology 2000, vol. 31, pp. 105–124, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. R. P. Darveau, G. Hajishengallis, and M. A. Curtis, “Porphyromonas gingivalis as a potential community activist for disease,” Journal of Dental Research, vol. 91, pp. 816–820, 2012. View at Publisher · View at Google Scholar
  6. M.F. Rivera, J. Y. Lee, M. Aneja, V. Goswami, L. Liu, and I. M. Velsko, “Polymicrobial with major periodontal pathogens induced periodontal disease and aortic atherosclerosis in hyperlipidemic ApoE(null) mice.,” PLoS One, vol. 8, Article ID e57178, 2013. View at Publisher · View at Google Scholar
  7. Y. Akamatsu, T. Yamamoto, K. Yamamoto et al., “Porphyromonas gingivalis induces myocarditis and/or myocardial infarction in mice and IL-17A is involved in pathogenesis of these diseases,” Archives of Oral Biology, vol. 56, no. 11, pp. 1290–1298, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. C. O. Bingham III and M. Moni, “Periodontal disease and rhenmatoid arthritis: the evidence accumulates for complex pathobiologic interactions,” Current Opinions in Rheumatology, vol. 25, pp. 345–353, 2013. View at Publisher · View at Google Scholar
  9. H. Koo, B. P. F. A. Gomes, P. L. Rosalen, G. M. B. Ambrosano, Y. K. Park, and J. A. Cury, “In vitro antimicrobial activity of propolis and Arnica montana against oral pathogens,” Archives of Oral Biology, vol. 45, no. 2, pp. 141–148, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Xiao, X. D. Zhou, J. Feng, Y. Q. Hao, and J. Y. Li, “Activity of nidus vespae extract and chemical fractions against Streptococcus mutans biofilms,” Letters in Applied Microbiology, vol. 45, no. 5, pp. 547–552, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Grenier and V. D. La, “Proteases of porphyromonas gingivalis as important virulence factors in periodontal disease and potential targets for plant-derived compounds: a review article,” Current Drug Targets, vol. 12, no. 3, pp. 322–331, 2011. View at Google Scholar · View at Scopus
  12. S. J. Qureshi, M. A. Khan, and M. Ahmad, “A survey of useful medicinal plants of Abbottabad in northern Pakistan,” Trakia Journal of Sciences, vol. 6, pp. 39–51, 2008. View at Google Scholar
  13. A. B. Cribb and J. W. Cribb, Wild Medicine in Australia, Collins, Sydney, Australia, 1981.
  14. R. Naidoo, Z. Gulube, I. Fenyvesi, and M. Patel, “Inhibitory activity of Dodonaea viscosa var. angustifolia extract against Streptococcus mutans and its biofilm,” Journal of Ethnopharmacology, vol. 144, pp. 171–174, 2012. View at Publisher · View at Google Scholar
  15. M. Patel, Z. Gulube, and M. Dutton, “The effect of Dodonaea viscosa var. angustifolia on Candida albicans proteinase and phospholipase production and adherence to oral epithelial cells,” Journal of Ethnopharmacology, vol. 124, no. 3, pp. 562–565, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. N. M. Khalil, J. S. Sperotto, and M. P. Manfron, “Antiinflammatory activity and acute toxicity of dodonaea viscosa,” Fitoterapia, vol. 77, no. 6, pp. 478–480, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Patel, M. Coogan, and J. S. Galpin, “Periodontal pathogens in subgingival plaque of HIV-positive subjects with chronic periodontitis,” Oral Microbiology and Immunology, vol. 18, no. 3, pp. 199–201, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. J. N. Eloff, “The antibacterial activity of 27 southern African members of the combretaceae,” South African Journal of Science, vol. 95, no. 3, pp. 148–152, 1999. View at Google Scholar · View at Scopus
  19. J.-E. Kim, H.-E. Kim, J.-K. Hwang, H.-J. Lee, H.-K. Kwon, and B.-I. Kim, “Antibacterial characteristics of curcuma xanthorrhiza extract on Streptococcus mutans biofilm,” Journal of Microbiology, vol. 46, no. 2, pp. 228–232, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Kramer, “A rapid microdilution technique for counting viable bacteria in food,” Laboratory Practice, vol. 26, no. 9, pp. 675–676, 1977. View at Google Scholar · View at Scopus
  21. A. Yamanaka, T. Kouchi, K. Kasai, T. Kato, K. Ishihara, and K. Okuda, “Inhibitory effect of cranberry polyphenol on biofilm formation and cysteine proteases of Porphyromonas gingivalis,” Journal of Periodontal Research, vol. 42, no. 6, pp. 589–592, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. L. E. Alksne and S. J. Projan, “Bacterial virulence as a target for antimicrobial chemotherapy,” Current Opinion in Biotechnology, vol. 11, no. 6, pp. 625–636, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Escaich, “Antivirulence as a new antibacterial approach for chemotherapy,” Current Opinion in Chemical Biology, vol. 12, no. 4, pp. 400–408, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. R. J. Nisengard and M. G. Newman, Oral Microbiology and Immunology, WB Saunders Company, Philadelphia, Pa, USA, 2nd edition, 1994.
  25. S. Duarte, S. Gregoire, A. P. Singh et al., “Inhibitory effects of cranberry polyphenols on formation and acidogenicity of Streptococcus mutans biofilms,” FEMS Microbiology Letters, vol. 257, no. 1, pp. 50–56, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. D. P. D. S. Leitão, A. A. Da Silva Filho, A. C. M. Polizello, J. K. Bastos, and A. C. C. Spadaro, “Comparative evaluation of in vitro effects of Brazilian green propolis and baccharis dracunculifolia extracts on cariogenic factors of Streptococcus mutans,” Biological and Pharmaceutical Bulletin, vol. 27, no. 11, pp. 1834–1839, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Maeyama, I. K. Kwon, Y. Mizunoe, J. M. Anderson, M. Tanaka, and T. Matsuda, “Novel bactericidal surface: catechin-loaded surface-erodible polymer prevents biofilm formation,” Journal of Biomedical Materials Research A, vol. 75, no. 1, pp. 146–155, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. V. Brochu, D. Grenier, K. Nakayama, and D. Mayrand, “Acquisition of iron from human transferrin by Porphyromonas gingivalis a role for Arg- and Lys-gingipain activities,” Oral Microbiology and Immunology, vol. 16, no. 2, pp. 79–87, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Grenier, S. Imbeault, P. Plamondon, G. Grenier, K. Nakayama, and D. Mayrand, “Role of gingipains in growth of Porphyromonas gingivalis in the presence of human serum albumin,” Infection and Immunity, vol. 69, no. 8, pp. 5166–5172, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. C. C. Bodet, M. Piché, F. Chandad, and D. Grenier, “Inhibition of periodontopathogen-derived proteolytic enzymes by a high-molecular-weight fraction isolated from cranberry,” Journal of Antimicrobial Chemotherapy, vol. 57, no. 4, pp. 685–690, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Okamoto, A. Sugimoto, K.-P. Leung, K. Nakayama, A. Kamaguchi, and N. Maeda, “Inhibitory effect of green tea catechins on cysteine proteinases in Porphyromonas gingivalis,” Oral Microbiology and Immunology, vol. 19, no. 2, pp. 118–120, 2004. View at Publisher · View at Google Scholar · View at Scopus